BiomX(PHGE) - 2024 Q4 - Annual Results

Business Update Exhibit 99.1 BiomX Reports Fourth Quarter and Full Year 2024 Financial Results and Provides Business and Program Updates Ness Ziona, Israel, March 25, 2025 -- (GLOBE NEWSWIRE) -- BiomX Inc. (NYSE American: PHGE, the "Company" or "BiomX"), a clinical-stage company advancing novel natural and engineered phage therapies that target specific pathogenic bacteria, today announced financial results for the fourth quarter and full year ended December 31, 2024, and provided program and business updat ...